Mitchell S. Cairo

27.5k total citations · 2 hit papers
507 papers, 14.9k citations indexed

About

Mitchell S. Cairo is a scholar working on Hematology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Mitchell S. Cairo has authored 507 papers receiving a total of 14.9k indexed citations (citations by other indexed papers that have themselves been cited), including 171 papers in Hematology, 161 papers in Oncology and 153 papers in Pathology and Forensic Medicine. Recurrent topics in Mitchell S. Cairo's work include Hematopoietic Stem Cell Transplantation (144 papers), Lymphoma Diagnosis and Treatment (141 papers) and Acute Lymphoblastic Leukemia research (120 papers). Mitchell S. Cairo is often cited by papers focused on Hematopoietic Stem Cell Transplantation (144 papers), Lymphoma Diagnosis and Treatment (141 papers) and Acute Lymphoblastic Leukemia research (120 papers). Mitchell S. Cairo collaborates with scholars based in United States, United Kingdom and France. Mitchell S. Cairo's co-authors include Michael Bishop, Carmella van de Ven, John E. Wagner, Sherrie L. Perkins, Bertrand Coiffier, Anas Younes, Erin Morris, Richard Sposto, Joanne Kurtzberg and Janet Ayello and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Mitchell S. Cairo

492 papers receiving 14.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Hematopoietic Engraftment and Survival in Adult Recipients of Umbilical-Cord Blood from Unrelated Donors

2001 643 citations John E. Wagner, Mitchell S. Cairo et al. profile →
Tumour lysis syndrome: new therapeutic strategies and classification

2004 639 citations Mitchell S. Cairo et al. British Journal of Haematology profile →

Peers

Countries citing papers authored by Mitchell S. Cairo

Since Specialization

Citations

This map shows the geographic impact of Mitchell S. Cairo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitchell S. Cairo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitchell S. Cairo more than expected).

Fields of papers citing papers by Mitchell S. Cairo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mitchell S. Cairo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitchell S. Cairo. The network helps show where Mitchell S. Cairo may publish in the future.

Co-authorship network of co-authors of Mitchell S. Cairo

This figure shows the co-authorship network connecting the top 25 collaborators of Mitchell S. Cairo. A scholar is included among the top collaborators of Mitchell S. Cairo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mitchell S. Cairo. Mitchell S. Cairo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Knockout of IL-1R1 Reduced Inflammation and Improved Survival in a Mouse Model of Recessive Dystrophic Epidermolysis Bullosa 2025 ·Journal of Investigative Dermatology ·(unknown), Rahim Hirani, Jian Pan, Marı́a José Ramı́rez, (unknown), Alexander Nyström, Mitchell S. Cairo, (unknown)	2
2	Modulation of Inflammation By Unrestricted Somatic Stem Cells (USSCs) to Suppress Fibrosis in Mice with Dystrophic Epidermolysis Bullosa 2024 ·Transplantation and Cellular Therapy ·(unknown), Rahim Hirani, Alexander Nyström, (unknown), (unknown), Jian Pan, Yanling Liao, Mitchell S. Cairo	1
3	Efficiently targeting neuroblastoma with the combination of anti-ROR1 CAR NK cells and N-803 in vitro and in vivo in NB xenografts 2024 ·SHILAP Revista de lepidopterología ·Yaya Chu, Gaurav Nayyar, (unknown), Dean A. Lee, M. Fevzi Özkaynak, (unknown), (unknown), (unknown), (unknown), Wen Luo, (unknown), (unknown), Gregory K. Behbehani, Stanley R. Riddell, (unknown), Mitchell S. Cairo	2
4	The Safety, Feasibility, and Efficacy of Ganciclovir Prophylaxis through Day +100 in Pediatric Allogeneic Stem Cell Transplantation (AlloSCT) Recipients: Bone Marrow Suppression May Limit Effectiveness 2021 ·Transplantation and Cellular Therapy ·(unknown), Allyson Flower, (unknown), (unknown), Lauren Harrison, Carmella van de Ven, Mitchell S. Cairo	1
5	Narsoplimab (OMS721), a Masp-2 Inhibitor, for the Treatment of Adult Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy (HSCT-TMA) 2021 ·Transplantation and Cellular Therapy ·Samer K. Khaled, Jaap Jan Boelens, Mitchell S. Cairo, Richard Champlin, Rafael F. Duarte, Sergio Giralt, Mehdi Hamadani, Vincent T. Ho, (unknown), Nelson Leung, Sebastian Mayer, (unknown), Olaf Penack, Miguel‐Angel Perales, Jameela Sathar, Michael Scordo, Sumithira Vasu, Alessandro Rambaldi	2
6	Combinatorial immunotherapy of N-803 (IL-15 superagonist) and dinutuximab with ex vivo expanded natural killer cells significantly enhances in vitro cytotoxicity against GD2⁺ pediatric solid tumors and in vivo survival of xenografted immunodeficient NSG mice 2021 ·Journal for ImmunoTherapy of Cancer ·Yaya Chu, Gaurav Nayyar, (unknown), Jeremy Rosenblum, Patrick Soon‐Shiong, Jeffrey T. Safrit, Dean A. Lee, Mitchell S. Cairo	31
7	The Safety and Efficacy of Granulocyte Transfusions in Pediatric Recipients with Severe Neutropenia 2021 ·Blood ·(unknown), (unknown), Jibran Ahmed, (unknown), Bruce S. Sachais, Delong Liu, Mitchell S. Cairo, Jeremy Rosenblum	1
8	Mature (non‐anaplastic, non‐cutaneous) T‐/NK‐cell lymphomas in children, adolescents and young adults: state of the science 2019 ·British Journal of Haematology ·Allyson Flower, Ana C. Xavier, Mitchell S. Cairo	8
9	Childhood, adolescent and young adult non‐Hodgkin lymphoma: current perspectives 2019 ·British Journal of Haematology ·Mitchell S. Cairo, Auke Beishuizen	31
10	IRF4 translocation status in pediatric follicular and diffuse large B‐cell lymphoma patients enrolled in Children's Oncology Group trials 2019 ·Pediatric Blood & Cancer ·Karen M. Chisholm, Jeffrey S. Mohlman, Michael Liew, Amanda Termuhlen, Mitchell S. Cairo, Thomas G. Gross, Sherrie L. Perkins, Rodney R. Miles	20
11	Advances in cellular and humoral immunotherapy – implications for the treatment of poor risk childhood, adolescent, and young adult B‐cell non‐Hodgkin lymphoma 2019 ·British Journal of Haematology ·Yaya Chu, (unknown), Amanda Termuhlen, Mitchell S. Cairo	13
12	Overall survival of children and adolescents with mature B cell non‐Hodgkin lymphoma who had refractory or relapsed disease during or after treatment with FAB/LMB 96: A report from the FAB/LMB 96 study group 2018 ·British Journal of Haematology ·Mitchell S. Cairo, Anne Aupérin, Sherrie L. Perkins, Ross Pinkerton, Lauren Harrison, Stanton Goldman, Catherine Patte	37
13	Disease burden and conditioning regimens in ASCT1221, a randomized phase II trial in children with juvenile myelomonocytic leukemia: A Children's Oncology Group study 2018 ·Pediatric Blood & Cancer ·Christopher C. Dvorak, Prakash Satwani, Elliot Stieglitz, Mitchell S. Cairo, Ha Dang, Qinglin Pei, Yun Gao, Donna A. Wall, Tali Mazor, Adam B. Olshen, Joel S. Parker, Samir B. Kahwash, Betsy Hirsch, Susana C. Raimondi, Neil Patel, Micah Skeens, Todd M. Cooper, Parinda A. Mehta, Stephan A. Grupp, Mignon L. Loh	23
14	A Phase I Study of Reduced-Intensity Conditioning and Allogeneic Stem Cell Transplantation Followed by Dose Escalation of Targeted Consolidation Immunotherapy with Gemtuzumab Ozogamicin in Children and Adolescents with CD33+ Acute Myeloid Leukemia 2016 ·Biology of Blood and Marrow Transplantation ·(unknown), Monica Bhatia, (unknown), (unknown), Erin Morris, Lauren Harrison, Carmella van de Ven, (unknown), K. Wolownik, (unknown), Lee Ann Baxter‐Lowe, (unknown), Olga Militano, Morris Kletzel, Mitchell S. Cairo	21
15	Targeting CD20+ Aggressive B-cell Non–Hodgkin Lymphoma by Anti-CD20 CAR mRNA-Modified Expanded Natural Killer Cells In Vitro and in NSG Mice 2014 ·Cancer Immunology Research ·Yaya Chu, Jessica Hochberg, (unknown), Janet Ayello, Carmella van de Ven, Matthew J. Barth, Myron S. Czuczman, Mitchell S. Cairo	143
16	The immunophenotype of T ‐lymphoblastic lymphoma in children and adolescents: a C hildren's O ncology G roup report 2012 ·British Journal of Haematology ·(unknown), Lynette M. Smith, James R. Anderson, Minnie Abromowitch, Dario Campana, Jeffrey Jacobsen, Mark A. Lones, Thomas G. Gross, Mitchell S. Cairo, Sherrie L. Perkins	69
17	Mobilization of Peripheral Blood Stem Cells with Paclitaxel and rhG-CSF in High-Risk Breast Cancer Patients 2002 ·Journal of Hematotherapy & Stem Cell Research ·Kenneth R. Meehan, Rebecca Slack, Edmund A. Gehan, Herbert B. Herscowitz, (unknown), (unknown), Mitchell S. Cairo, Marc E. Lippman	4
18	Cord Blood Transplantation Study (COBLT): Cord Blood Bank Standard Operating Procedures 1998 ·Journal of Hematotherapy ·John K. Fraser, Mitchell S. Cairo, Elizabeth L. Wagner, Paul R. McCurdy, L.A. Baxter-Lowe, (unknown), Nancy A. Kernan, Michael Lill, (unknown), John E. Wagner, Charles H. Wallas, Joanne Kurtzberg	84
19	Immunomagnetic Separation of CD34 ⁺ Cells from Human Bone Marrow, Cord Blood, and Mobilized Peripheral Blood 1993 ·Journal of Hematotherapy ·Lori Ishizawa, Giao Hangoc, Carmella van de Ven, Mitchell S. Cairo, J Burgess, Virginia H. Mansour, Adrian P. Gee, A Hardwick, Christie M. Traycoff, Edward F. Srour, Robert S. Hoffman, Ping‐Yee Law	18
20	Immunomagnetic Positive Selection and Colony Culture of CD34 ⁺ Cells from Blood 1993 ·Journal of Hematotherapy ·Ping‐Yee Law, Lori Ishizawa, Carmella van de Ven, J Burgess, A Hardwick, (unknown), Adrian P. Gee, Mitchell S. Cairo	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact